$0.94 EPS Expected for Varian Medical Systems, Inc. (VAR)

July 18, 2017 - By Kurt Siggers

 $0.94 EPS Expected for Varian Medical Systems, Inc. (VAR)
Investors sentiment increased to 0.9 in Q4 2016. Its up 0.01, from 0.89 in 2016Q3. It improved, as 38 investors sold Varian Medical Systems, Inc. shares while 188 reduced holdings. 59 funds opened positions while 144 raised stakes. 88.84 million shares or 2.22% less from 90.86 million shares in 2016Q3 were reported.
Wellington Gru Llp holds 1.70 million shares or 0.04% of its portfolio. Edgestream Prns L P holds 4,238 shares. North American Corporation holds 0.08% in Varian Medical Systems, Inc. (NYSE:VAR) or 5,300 shares. Srb Corp stated it has 0.02% in Varian Medical Systems, Inc. (NYSE:VAR). Btim holds 0.25% or 175,867 shares in its portfolio. Independent Order Of Foresters invested 0.28% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Next Fincl Group has 0% invested in Varian Medical Systems, Inc. (NYSE:VAR) for 70 shares. New York State Common Retirement Fund has invested 0.06% in Varian Medical Systems, Inc. (NYSE:VAR). Regions Fin Corp accumulated 2,604 shares or 0% of the stock. Orrstown Fincl Services Inc has invested 0.06% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). 48,500 are held by Needham Invest Limited Co. Nomura Asset Management Co, a Japan-based fund reported 73,130 shares. Norinchukin Natl Bank The holds 0.04% in Varian Medical Systems, Inc. (NYSE:VAR) or 21,266 shares. Ent reported 69 shares. Veritable Lp stated it has 15,320 shares.

Since February 22, 2017, it had 0 buys, and 14 insider sales for $12.71 million activity. $355,623 worth of Varian Medical Systems, Inc. (NYSE:VAR) shares were sold by KUO JOHN W. On Monday, June 12 the insider KENNEDY KOLLEEN T sold $110,000. BOSTROM SUSAN L had sold 3,589 shares worth $326,902. 11,302 shares were sold by LARET MARK R, worth $944,408 on Wednesday, February 22. 16,000 Varian Medical Systems, Inc. (NYSE:VAR) shares with value of $1.65M were sold by GUERTIN TIMOTHY E.

Investors wait Varian Medical Systems, Inc. (NYSE:VAR) to report on July, 26. its quarterly earnings Wall Street analysts expect $0.94 EPS, down $0.28 or 22.95 % from last year’s $1.22 same quarter earnings. This translates into $87.61 million profit for VAR giving the stock a 28.19 P/E. This is assuming the current $0.94 EPS is accurate. Varian Medical Systems, Inc.’s Wall Street analysts see 5.62 % EPS growth, taking into account the $0.89 EPS reproted in the previous quarter, The stock decreased 0.18% or $0.19 during the last trading session, reaching $106.01. About 466,948 shares traded. Varian Medical Systems, Inc. (NYSE:VAR) has risen 29.46% since July 18, 2016 and is uptrending. It has outperformed by 12.76% the S&P500.

Varian Medical Systems, Inc. (NYSE:VAR) Ratings Coverage

Among 10 analysts covering Varian Medical Systems Inc. (NYSE:VAR), 4 have Buy rating, 1 Sell and 5 Hold. Therefore 40% are positive. Varian Medical Systems Inc. had 20 analyst reports since August 27, 2015 according to SRatingsIntel. Robert W. Baird downgraded it to “Neutral” rating and $82 target in Tuesday, October 20 report. The stock of Varian Medical Systems, Inc. (NYSE:VAR) has “Sector Perform” rating given on Monday, January 23 by RBC Capital Markets. The rating was upgraded by Citigroup to “Buy” on Monday, May 8. The rating was maintained by RBC Capital Markets with “Hold” on Wednesday, June 21. The stock has “Sell” rating by Evercore on Thursday, January 26. On Tuesday, January 12 the stock rating was reinitiated by Barrington Research with “Outperform”. The firm has “Sector Perform” rating given on Tuesday, December 22 by RBC Capital Markets. The stock of Varian Medical Systems, Inc. (NYSE:VAR) earned “Outperform” rating by Barrington Research on Friday, January 27. The firm has “Neutral” rating by Citigroup given on Thursday, November 12. The stock has “Sell” rating by Goldman Sachs on Monday, September 28.

Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company has market cap of $9.88 billion. The Firm also has Varian Particle Therapy and the activities of the Ginzton Technology Center (GTC). It has a 33.46 P/E ratio. The Company’s VPT business develops, designs, makes, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer.

More recent Varian Medical Systems, Inc. (NYSE:VAR) news were published by: Gurufocus.com which released: “Smithbridge Asset Management Inc Buys InterDigital Inc, McKesson Corp …” on July 17, 2017. Also Nasdaq.com published the news titled: “Zacks Industry Outlook Highlights: Varian Medical Systems, Inogen, Edwards …” on July 07, 2017. Zacks.com‘s news article titled: “Varian Rides on Oncology and Proton Therapy Businesses” with publication date: June 28, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.